Philips is a global healthcare company focused on improving health and well-being through innovative technology. Their offerings include monitoring and analytics systems that support healthcare providers in delivering personalized treatment and patient care.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
Amsterdam (Netherlands) 1891 +10000 NA 9 months ago
Masimo Corporation specializes in developing non-invasive patient monitoring technologies and solutions, including advanced sensors and devices for tracking various physiological parameters. Their products also encompass remote monitoring and management solutions aimed at enhancing patient care and safety.
Masimo Corporation, founded in 1989 and headquartered in Irvine, California, is a medical technology company that develops, manufactures, and markets innovative non-invasive patient monitoring measurements, sensors and devices, hospital automation and connectivity solutions, telehealth solutions, and consumer health and wellness devices. Masimo is best known for its pulse oximetry technology, Masimo Signal Extraction Technology® (SET®) — which today is considered to be modern pulse oximetry. Masimo SET® addresses the limitations of conventional pulse oximetry, such as its poor performance during patient motion or low perfusion. Founder and CEO Joe Kiani was inspired to develop more reliable, accurate technology after observing ineffective pulse oximetry in the neonatal care unit (NICU). Masimo’s pulse oximetry is at the heart of many of its monitoring devices and products. In 2023, SET®’s origin — as a way to more reliably monitor NICU babies — came full circle with the introduction of Masimo Stork™, a baby monitor that uses SET® and other advanced technologies to help parents track their babies’ health indicators at home. In addition to Masimo SET®, the company has developed numerous noninvasive measurements (collectively known as the rainbow SET® family of measurements), a suite of advanced devices like the Root® patient monitoring and connectivity platform, many other innovative bedside, handheld, and tetherless devices, and remote patient monitoring and management solutions like Masimo Patient SafetyNet™ and Masimo SafetyNet These devices and solutions help caregivers monitor numerous physiological parameters including blood oxygen saturation (SET® SpO2), total hemoglobin (SpHb®) carboxyhemoglobin (SpCO®), fluid responsiveness (PVi®), methemoglobin (SpMet), respiration rate from the pleth (RRp®), brain function while sedated (SedLine®), regional and cerebral oximetry (O3®), cardiac output (LiDCO™), end-tidal carbon dioxide and other capnography measurements (NomoLine®), acoustic respiratory rate (RRa®), and more. Masimo also develops therapeutic products like Masimo softFlow™ which delivers respiratory support to patients with spontaneous breathing. Additionally, Bridge™ by Masimo is a non-drug device that alleviates symptoms of opioid withdrawal through neuromodulation — making recovery safer and easier. Masimo also offers the first FDA-authorized device to alert users in the event of an opioid overdose, Opioid Halo™, and wearable devices like the Masimo W1™ advanced health tracking watch. The company sells its products to end-users through direct sales and distributors, as well as to original equipment manufacturers (OEMs) and other partners to incorporate into their products.
Irvine (United States) 1989 1001 - 5000 $957.55M Post-IPO Equity, $750.00M, August 15, 2022 9 months ago
Health Recovery Solutions provides a telehealth and remote monitoring platform that enhances patient engagement and reduces hospital readmissions through real-time monitoring and education. Their solutions are designed to support various healthcare settings, improving clinical outcomes and patient satisfaction.
Health Recovery Solutions helps reduce readmissions (Congestive Heart Failure, Heart Attack, Pneumonia, Diabetes, COPD) for hospitals and ACOs through mobile and cloud-based early warning system. The company develops a patient engagement platform that specifically targets adherence and education for patients, along with engaging caregivers and care coordination staff to support the patient when needed and intervene and prevent 30-day readmissions and even beyond. This has a three-pronged benefit for the provider including proper workflow optimization, revenue generation for transitional care activities, and transparency of medical information across the care continuum.
Hoboken (United States) 2012 51 - 200 $87.07M Series C, $70.00M, March 9, 2021 9 months ago
Accuhealth is a healthcare technology firm that specializes in remote patient monitoring, providing real-time access to vital information for physicians to enhance patient care. Their platform aims to improve health outcomes and patient satisfaction while reducing healthcare costs.
Accuhealth is a Healthcare Technology company. Having created the first Healthcare Operations Center for remote patient monitoring, Accuhealth improves primary physician care within the clinical setting and the home. With access to real-time vital information, physicians improve outcomes, increase patient satisfaction, and reduces costs.
Mcallen (United States) 2018 11 - 50 Private Equity, April 16, 2024 9 months ago
HealthSnap offers a comprehensive platform for managing chronic diseases through remote monitoring and care coordination, utilizing real-time data from connected devices to enhance patient outcomes. Their services include automated care management and integration with electronic health records, making it easier for healthcare providers to deliver proactive care.
HealthSnap is an integrated Virtual Care Management Platform that helps healthcare organizations improve patient outcomes, reduce utilization, and diversify revenue streams. From chronic disease-agnostic Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) to AI-guided care coordination, virtual care delivery, automated care management billing, population analytics - and so much more - HealthSnap is the simplest way to manage chronic conditions remotely.
Miami (United States) 2015 51 - 200 $46.60M Series B, $25.00M, February 21, 2024 9 months ago
Carevive Systems specializes in personalized cancer care plans and utilizes remote symptom monitoring through electronic patient-reported outcomes (ePROs) to enhance patient engagement and improve clinical outcomes. Their platform integrates with existing EHR systems to provide real-time data and support for oncology practices.
Carevive Systems provides personalized and dynamic cancer care plans for patients that improve clinical outcomes and enable oncology practices to operate in emerging value-based models. Its care plans continuously update to provide ongoing guidance to patients based on their experiences throughout the journey. Located in North Miami, Florida.
Miami (United States) 2013 11 - 50 $40.16M Acquired, June 2024 9 months ago
Medsensio effectively adopts remote monitoring technologies, advances clinical trials, and identifies digital biomarkers through its comprehensive platform.
Developer of a remote monitoring platform intended to provide all patient monitoring needs in one application. The company's platform turns health data into actionable points and provides predictive, personalized digital care services, enabling patients to improve their lives and reducing the cost of chronic care delivery.
Tromsø (Norway) 2017 1 - 10 NA 9 months ago
Empatica develops AI-enabled wearables and a health monitoring platform that continuously collects physiological data, providing real-time insights for patients and researchers. Their technology is designed for clinical trials and remote health monitoring, utilizing validated digital biomarkers for various health conditions.
Empatica designs and develops AI-enabled wearables, software, and digital biomarkers, to push the boundaries in health monitoring, forecasting, treatment, and research. Empatica’s platform uses a combination of biosensors to detect unique components of human physiology: providing AI-enabled tools advancing the forecasting, monitoring, research, and treatment of multiple conditions.
Cambridge (United States) 2011 51 - 200 $33.73M Series B, $25.95M, August 2, 2022 9 months ago
ActiGraph provides wearable devices and software solutions for monitoring physical activity, sleep, and mobility, primarily for research and clinical trials. Their technology supports data collection and analysis to enhance clinical outcomes and patient care.
ActiGraph is a provider of objective, 24 hour physical activity measurement solutions for the global scientific community. It is dedicated to providing its clients with accurate, innovative, and cost effective objective monitoring solutions to help them achieve their research and clinical data collection, analysis, and management objectives. ActiGraph’s aim is to improve world health by providing accurate and scientifically validated activity and sleep monitoring hardware and software solutions to research, pharmaceutical, healthcare, and wellness organizations. Through close and collaborative relationships with its clients, the company strives to proactively identify trends and understand the changing landscape of its industry, allowing it to deliver hardware, software, and data management solutions to meet the evolving needs of the research community. ActiGraph is headquartered in Pensacola, F.L.
Pensacola (United States) 2004 11 - 50 Acquired, May 2020 9 months ago
Ixico is a U.K.-based company specializing in clinical trial services, particularly in neuroimaging and digital biomarker solutions for neurological disorders. They provide comprehensive support for drug development analytics and have a global network of imaging centers for efficient trial execution.
Ixico is a U.K.-based company that provides clinical trial services worldwide. The company offers end-to-end imaging services in various therapeutic areas, primarily in the fields of oncology and neurology to the pharmaceutical industry, biotech companies, academia, and medical charities. Ixico offers technology developing solutions for the treatment of diseases, including predominantly dementia and other neuro degeneration diseases. It is based in London, England.
London (United Kingdom) 1995 51 - 200 $17.84M Post-IPO Equity, $5.23M, October 9, 2024 9 months ago
Alacrity Care effectively employs remote monitoring technologies and identifies digital biomarkers to enhance patient care and advance clinical trials.
Alacrity Care develops end-to-end solutions that address AE healthcare management needs. They provide integrated data collection and leverage a spectrum of wearables, spot assessment tools, and point-of-care blood analysis. They also provide devices to design a monitoring approach focused on specific AE detection needs. They are specified in digital therapeutics, digital health, and digital care companions.
Los Angeles (United States) 2012 1 - 10 NA 9 months ago
Evidation develops a health data analytics platform that collects and analyzes everyday behavior data to generate insights about health and diseases. They focus on empowering individuals to participate in health research and improve health outcomes through real-world data.
Evidation measures health in everyday life and enables anyone to participate in groundbreaking research and health programs. Built upon a foundation of user privacy and control over permissioned health data, Evidation's Achievement platform is trusted by millions of individuals—generating data with unprecedented speed, scale, and rigor. We partner with leading healthcare companies to understand health and disease outside the clinic walls. Guided by our mission to enable and empower everyone to participate in better health outcomes, Evidation is working to bring people individualized, proactive, and accessible healthcare—faster. Founded in 2012, Evidation Heath is headquartered in California. We collaborate as a distributed team with additional offices around the globe. To learn more, visit evidation.com, or follow us on Twitter @evidation
San Mateo (United States) 2012 51 - 200 $259.00M Series E, $153.00M, March 22, 2021 9 months ago
Coviu is a telehealth platform that enhances virtual consultations with AI-backed clinical tools and a variety of integrated applications. It offers features like remote patient monitoring and a marketplace of tools tailored for diverse healthcare specialties.
Coviu is a telehealth startup that helps doctors and health practitioners with AI-backed clinical tools to make the video calling experience with the patient even better than actually seeing the patient in real life. The company offers consultations regarding cardiology, dentistry, dermatology, diabetes, dietetics, endocrinology, Endoscopy. general practice, beauty, naturopathy, nutrition, homeopathy, occupational therapy, child health and pediatrics, orthopedics, psychology, psychotherapy, plastic surgery, speech and language therapy, urology, women’s health, and many more. Its video consultations are enhanced with a range of in-call clinical tools, and its software integrates seamlessly with a range of practice management systems.
South Brisbane (Australia) 2015 51 - 200 $7.32M Series A, $6.00M, December 7, 2020 9 months ago
Koneksa Health excels in remote patient monitoring and digital biomarker development, enhancing clinical trials and disease tracking.
Koneksa Health is a healthcare data analytics company that helps researchers incorporate emerging technologies (bio-sensors, activity trackers, mobile-based questionnaires, etc.) into their clinical studies. Their Koneksa Compare software dashboard enables the collection, visualization, and analysis of these patient-generated data sets. Koneksa currently supports academic and life sciences researchers, expands the universe of data that can be analyzed while also removing subjective characteristics from clinical endpoints. It was founded in 2015 and is based in New York, United States.
New York (United States) 2015 51 - 200 $70.65M Grant, August 8, 2022 9 months ago
TytoCare is a mobile-health platform that enables self-physical examinations and remote diagnoses through its telehealth products. Their solutions include a modular examination tool and a cloud-based platform for sharing exam data and conducting live video consultations.
TytoCare is a mobile-health platform and device, that allows anyone to perform self-physical examination and remote diagnosis. Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit and include a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use.
New York (United States) 2011 51 - 200 $205.70M Series E, $49.00M, August 3, 2023 9 months ago
Altoida is pioneering a platform for assessing brain health using augmented reality and machine learning, focusing on early detection of cognitive impairments. Their technology aims to provide objective evaluations of neurological conditions, enhancing clinical trial outcomes and monitoring disease progression.
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet. Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR), and artificial intelligence (AI). Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
Washington (United States) 2016 11 - 50 $24.75M Series A, $14.00M, March 30, 2022 9 months ago
Verily is a health technology company that focuses on research, care, and health financing, utilizing technology and data science to enhance personalized healthcare. They develop tools and products aimed at improving health outcomes and accelerating evidence generation in the healthcare sector.
Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information about Verily please visit verily.com. The company was founded in 2015 and is based in San Francisco, California, United States.
South San Francisco (United States) 2015 1001 - 5000 $3.51B Grant, $14.70M, April 30, 2025 9 months ago
VivoSense excels in remote patient monitoring and the development of digital biomarkers, significantly advancing clinical trials and healthcare research.
VivoSense, also known as Vivonoetics are a data analysis and software company specializing in wearable sensor physiological monitoring solutions for research and clinical trials.
Newport Coast (United States) 2010 11 - 50 $27.00M Grant, January 9, 2023 9 months ago
Orikami excels in remote monitoring technologies, advancing clinical trials, and developing digital biomarkers for personalized healthcare.
Orikami offers 3 service lines that leverage our state-of-the-art data science expertise in health. They work patients included and according to the principles of ISO27001 (data security) and ISO13485 (medical quality management).
Nijmegen (Netherlands) 2011 11 - 50 $659.06K Seed, $659.00K, October 9, 2019 9 months ago
MyHealios effectively employs remote monitoring technologies and focuses on the identification and validation of digital biomarkers to enhance clinical trials and patient care.
Combining consumer devices' sensor data with AI, Dreams generates Digital Biomarkers to improve MS diagnosis and treatment monitoring. dreaMS is a Software as Medical Device (CE-Mark) designed to assess neurological functions using novel Digital Biomarkers focused in the following domains: Movement, Balance, Dexterity and Vision dreaMS is the product of a collaboration between Healios and RC2NB, a neuroscience research foundation connected to Universitätsspital Basel led by Professor L Kappos.
Flemington, New Jersey (United States) 2011 11 - 50 NA 9 months ago
nference develops advanced technologies that leverage real-world data for remote monitoring, optimizing clinical trials, and identifying digital biomarkers.
Predible Health is an Artificial Intelligence platform in Radiology, tailored for Specialists.LungIQ is designed from the ground-up to deliver the most accurate and quantitative reports for referring pulmonologists. Built using deep learning technology trained on millions of CT images
Bangalore (India) 2016 11 - 50 Acquired, May 2022 9 months ago
Circadic effectively utilizes remote monitoring technologies to advance clinical trials and identify digital biomarkers, contributing to the development of digital health solutions.
The company specializes in piloting digital biomarker discovery studies and aims to improve lives by using unobtrusive means. They partner with pharmaceutical and research organizations to reimagine the future of digital medicine.
1 - 10 NA 9 months ago
Current Health effectively adopts remote monitoring technologies, advances clinical trials, and identifies digital biomarkers, making it a strong fit for the specified requirements.
Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.
Boston (United States) 2015 51 - 200 $492.72M Acquired, October 2021 9 months ago
Indivi effectively utilizes remote monitoring technologies to identify and validate digital biomarkers, advancing clinical trials in neuroscience.
Indivi is a Medical Device Software Manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies. With novel, validated and patented Digital Biomarkers, we aim at measuring – with unprecedented sensitivity – changes in motor and cognitive functions in patients with neurological disorders. These novel biomarkers will establish a new standard for both pharmacological research and clinical practice.
Basel (Switzerland) 2012 51 - 200 $4.20M Seed, August 31, 2022 9 months ago
The company excels in remote monitoring and digital biomarker identification, supporting clinical trials and advancing digital health technologies.
Developer of digital biomarker sensors based in Washington, Virginia. The company offers raw sensor data, participant activity tracking, anonymization of data, data collection, clinical trials, digital biomarker datasets, and more.
Washington (United States) 2022 1 - 10 NA 9 months ago
